AllianceBernstein’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AllianceBernstein's TXG Position: Q3 2026 in Review
AllianceBernstein increased its 10x Genomics (TXG) stake by 4.1% in Q3 2026, buying an estimated $337K and bringing the position to 146,334 shares worth $13.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1098.
AllianceBernstein first reported a position in TXG in Q3 2019 and has held it in 29 quarters since. The position peaked at $153M in Q3 2020. 491 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- AllianceBernstein held 146,334 shares of 10x Genomics worth $13.2M as of Q3 2026.
- AllianceBernstein bought 5,753 10x Genomics shares in Q3 2026, an estimated $337K.
- 10x Genomics made up ﹤0.01% of AllianceBernstein's portfolio in Q3 2026, its #1098 holding.
- AllianceBernstein first reported a position in 10x Genomics in Q3 2019 and has held it in 29 quarters since.
- AllianceBernstein's 10x Genomics position peaked at $153M in Q3 2020.
- 491 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on AllianceBernstein's 13F filing for Q3 2026, filed 16 Nov 2026.